IKS Health announced robust financial results for the second quarter ended September 30, 2026. The company reported a 103.9% year-over-year growth in revenue, reaching INR 15,925 million. EBITDA also saw a significant increase of 62.5% YoY to INR 4,415 million. These strong results are attributed to continued momentum and the successful consolidation of the TruBridge acquisition.
IKS Health Announces Strong Q2 FY27 Financial Performance
IKS Health (NSE: IKS) today announced its financial results for the second quarter of Fiscal Year 2027 (Q2 FY27), ending September 30, 2026. The company demonstrated significant growth, with revenue surging by 103.9% year-over-year to INR 15,925 million. This impressive performance was also reflected in the Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA), which grew by 62.5% YoY to INR 4,415 million. Profit After Tax (PAT) increased by 20.4% YoY to INR 2,177 million.
Key Financial Highlights (Q2 FY27 vs. Q2 FY26)
- Revenue: INR 15,925 Mn (up 103.9% YoY)
- EBITDA: INR 4,415 Mn (up 62.5% YoY)
- PAT: INR 2,177 Mn (up 20.4% YoY)
- EBITDA Margin: 27.7%
- PAT Margin: 13.7%
Impact of TruBridge Acquisition
The strong financial performance in Q2 FY27 was significantly bolstered by the successful consolidation of the TruBridge acquisition, which contributed 82 days to the quarter. The company highlighted that the TruBridge acquisition is PAT/EPS accretive from Q2 FY’27 itself. Sachin K. Gupta, Founder and Global CEO of IKS Health, stated that the integration of IKS Health and TruBridge marks a defining inflection point, advancing the company’s vision to build an Al-native intelligent operating system for healthcare.
Customer Wins and Strategic Growth
The press release also detailed several key customer wins, underscoring the company’s expanding market presence. These include partnerships with White-Wilson Medical Center for comprehensive RCM optimization, Evolve Orthopedic Partners for end-to-end RCM services, and continued growth with Augusta Health. Furthermore, strategic collaborations with UMass Memorial Health for data migration and a new partnership with MISH Hospital & Clinics to implement a unified EHR platform were highlighted.
Leadership Commentary
Nithya Balasubramanian, Group CFO of IKS Health, commented on the results, stating, “Our performance in Q2 FY27 reflects the structural expansion of our operating scale and earnings power. Delivering INR 15,925 Mn in revenue, up 78.2% QoQ, demonstrates early financial accretion of the TruBridge integration alongside sustained organic revenue momentum.” She further emphasized the focus on realizing operational synergies and driving sustainable, long-term shareholder value.
About IKS Health
IKS Health is a leading technology-enabled healthcare solutions provider and care enablement platform. Founded in 2006, the company integrates AI, agentic workflows, and human expertise to optimize healthcare operations, improve outcomes, and drive financially sustainable growth. IKS Health partners with health systems, physician groups, and specialty practices across the United States.
Source: BSE
